The FDA has approved an injectable form of the drug Imitrex for use in the treatment of migraine headaches. Patients are dispensed a two-dose autoinjector with 4mg doses. While the medication is only for certain kinds of migraines, those patients that can benefit from it could see results in as little as ten minutes.
Side effects are similar to those of inhaled or oral Imitrex, with the addition of possible burning or skin irritation at the injection site. Patients with cardiovascular diseases should be closely monitored while taking this medication.
From WJLA-TV